SPY301.55-1.42 -0.47%
DIA252.78-1.57 -0.62%
IXIC9,370.10+1.11 0.01%

Orchard Therapeutics Q1 EPS $(0.510), Inline

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.510) per share which met the analyst consensus estimate. This is a 45.71 percent decrease over losses of $(0.350) per share from the same period last

Benzinga · 05/07/2020 11:24

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.510) per share which met the analyst consensus estimate. This is a 45.71 percent decrease over losses of $(0.350) per share from the same period last year.